ملخص
A 73-year-old woman with rosacea, who had started treatment with erythromycin stearate 2 g/d, developed asymptomatic liver injury. The drug was discontinued and the laboratory findings of liver damage disappeared within 11 days. This is the first report of erythromycin stearate-induced asymptomatic hepatotoxicity.
اللغة الأصلية | الإنجليزيّة |
---|---|
الصفحات (من إلى) | 601-602 |
عدد الصفحات | 2 |
دورية | Drug Intelligence and Clinical Pharmacy |
مستوى الصوت | 20 |
رقم الإصدار | 7-8 |
المعرِّفات الرقمية للأشياء | |
حالة النشر | نُشِر - 1986 |
منشور خارجيًا | نعم |